With a market cap of $31.5 billion, GE HealthCare Technologies Inc. (GEHC) is a global medical technology company that develops and manufactures advanced diagnostic imaging equipment, ultrasound systems, patient monitoring devices, and pharmaceutical diagnostics products. Headquartered in Chicago, Illinois, the company provides technologies and AI-powered digital solutions that help healthcare professionals diagnose diseases, guide treatments, and monitor patients.
The company is expected to announce its fiscal Q3 2026 results before the market opens on Wednesday, Oct. 28. Ahead of this event, analysts forecast GEHC to report an adjusted EPS of $1.21, up 13.1% from $1.07 in the year-ago quarter. It has exceeded Wall Street's earnings estimates in three of the past four quarters, while missing on another occasion.